Exisulind shows positive results in the prevention of precancerous colon polyps.
D011125:Adenomatous Polyposis Coli / Q000188:drug therapy*; D016588:Anticarcinogenic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic; D004311:Double-Blind Method; D006801:Humans; D011230:Precancerous Conditions / Q000517:prevention & control*; D013467:Sulindac / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D016588:Anticarcinogenic Agents; D013467:Sulindac; C025463:sulindac sulfone